Del Rosario, Jaime L.

HRN: 08-51-34  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/24/2023
12/29/2023
IV
600mg
Q8
Infected Wound DM Foot
Waiting Final Action 
11/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/26/2023
12/24/2023
IV
1.5gram
Q8hrs
Infected Wound, DM Foot
Waiting Final Action 
12/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/04/2023
12/10/2023
IV
1.5gm
Q8
Infecred Wound DM Foot
Waiting Final Action 
12/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/04/2023
12/10/2023
IV
600mg
Q8
Infected Wound DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: